Targeting the translation machinery in cancer

M Bhat, N Robichaud, L Hulea, N Sonenberg… - Nature reviews Drug …, 2015 - nature.com
Dysregulation of mRNA translation is a frequent feature of neoplasia. Many oncogenes and
tumour suppressors affect the translation machinery, making aberrant translation a …

Targeting the eIF4F translation initiation complex: a critical nexus for cancer development

J Pelletier, J Graff, D Ruggero, N Sonenberg - Cancer research, 2015 - AACR
Elevated protein synthesis is an important feature of many cancer cells and often arises as a
consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F) …

[HTML][HTML] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Abstract The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …

Protein synthesis control in cancer: selectivity and therapeutic targeting

JR Kovalski, D Kuzuoglu‐Ozturk, D Ruggero - The EMBO Journal, 2022 - embopress.org
Translational control of mRNAs is a point of convergence for many oncogenic signals
through which cancer cells tune protein expression in tumorigenesis. Cancer cells rely on …

Signalling to eIF4E in cancer

N Siddiqui, N Sonenberg - Biochemical Society Transactions, 2015 - portlandpress.com
Translational control plays a critical role in the regulation of gene expression in eukaryotes
and affects many essential cellular processes, including proliferation, apoptosis and …

Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers

M Pourdehnad, ML Truitt, IN Siddiqi… - Proceedings of the …, 2013 - National Acad Sciences
Myc is one of the most commonly deregulated oncogenes in human cancer, yet therapies
directly targeting Myc hyperactivation are not presently available in the clinic. The …

Structure-based design of pyridone–aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 …

SH Reich, PA Sprengeler, GG Chiang… - Journal of medicinal …, 2018 - ACS Publications
Dysregulated translation of mRNA plays a major role in tumorigenesis. Mitogen-activated
protein kinase interacting kinases (MNK) 1/2 are key regulators of mRNA translation …

The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment

M Bartish, MJ Abraham, C Gonçalves… - Nature Reviews …, 2023 - nature.com
Cells can rapidly adjust their proteomes in dynamic environments by regulating mRNA
translation. There is mounting evidence that dysregulation of mRNA translation supports the …

Eukaryotic translation initiation factors in cancer development and progression

R Spilka, C Ernst, AK Mehta, J Haybaeck - Cancer letters, 2013 - Elsevier
Eukaryotic gene expression is a complicated process primarily regulated at the levels of
gene transcription and mRNA translation. The latter involves four main steps: initiation …

RNA-binding proteins in cancer drug discovery

JB Bertoldo, S Müller, S Hüttelmaier - Drug discovery today, 2023 - Elsevier
Highlights•RNA-binding proteins (RBPs) are essential for tumorigenesis, immune evasion,
invasion, migration and metastasis, hence promising drug targets in cancer therapy.•Small …